China
Africa
Explore chapters and articles related to this topic
Face Addiction
Published in Sandra Rasmussen, Developing Competencies for Recovery, 2023
According to the Diagnostic and Statistical Manual of Mental Disorders (5th ed.), substance-related disorders encompass ten separate classes of drugs including alcohol; caffeine; cannabis; hallucinogens; inhalants; opioids; sedatives, hypnotics, and anxiolytics; stimulants; tobacco; and other or unknown substances. The DSM-5 includes diagnostic criteria and codes for substance use, intoxication, and withdrawal for each of these classes of drugs. Note: the DSM-5-TR was published in March 2022. There are no major changes from DSM-5 in the diagnostic criteria. The DSM-5-TR uses ICD-10-CM codes, with anticipation of ICD 11. ICD-10-CM stands for the International Classification of Diseases, 10th Edition, Clinical Modification. There is more attention to culture, racism, and discrimination in the DSM-5-TR.
Developing Education and Treatment Protocols for Substance Use Disorders That Are Socially Responsible, Accountable, and Integrated
Published in Sahar Swidan, Matthew Bennett, Advanced Therapeutics in Pain Medicine, 2020
There are two groups of substance-related disorders: substance use disorders and substance-induced disorders. Substance use disorders are patterns of symptoms resulting from the use of a substance that you continue to take, despite experiencing problems as a result.Substance-induced disorders, including intoxication, withdrawal, and other substance/medication-induced mental disorders, are detailed alongside substance use disorders.
Substance abuse
Published in Laeth Sari Nasir, Arwa K Abdul-Haq, Caring for Arab Patients, 2018
Treatment of substance-related disorders should always involve family members; guilt, anger and blame often persist even after sobriety is attained. These unresolved conflicts or family patterns may lead to relapse,3 or find expression in the development of substance-related disorders by another family member.4
Does self-concealment and self-compassion differentially influence substance use for male versus female adolescents?
Published in Journal of Substance Use, 2023
Doris Chinelo Chinweuba, Chuka Mike Ifeagwazi, Anthonia Ukamaka Chinweuba, JohnBosco Chika Chukwuorji
Initiation of substance use often starts within the adolescence stage due to the storm and stress of the transitional stage (Burger et al., 2000; Pretorius, 1998); hence, adolescents are considered an important target group for interventions. Identifying the predictors of substance use will facilitate the much-needed interventions to curtail the problem and reduce the risk of developing substance-related disorders in the Niger Delta. However, little research exists on personal factors within the “self” domain that may influence the use of psychoactive drugs among youths in sub-Saharan Africa. The present study examined whether self-concealment and self-compassion will predict the use of psychoactive substances; and whether the predictive strengths of these variables differ for male and female adolescents in the Niger Delta region.
Did the pattern of use of zolpidem change since the enforcement of a new prescription rule? A latent class analysis using the French health insurance database
Published in Expert Opinion on Drug Safety, 2022
Marion Istvan, Morgane Rousselet, Edouard-Jules Laforgue, Marylène Guerlais, Marie Gérardin, Pascale Jolliet, Fanny Feuillet, Caroline Victorri-Vigneau
The assessment of patterns of use of psychotropic medications is essential to detecting substance-related disorders. Substance-related disorders correspond to a loss of control of the use of a psychoactive substance and can be defined according to the Diagnostic and Statistical Manual of Mental Disorders – 5 (DSM-5) on the basis of some criteria, including tolerance, withdrawal, use of the substance often in larger amounts or over a longer period than intended, the persistent desire or repeated attempts to reduce or control the use of the medication, spending excessive amounts of time obtaining or using the substance, giving up activities because of the use of the substance, and persistence of the use of the medicine despite physical or psychological problems because of that use [19]. In addition to the variety of possible substance-related disorder profiles, a common feature is the need for a high volume and/or increasing dose of medication, which can lead to drug-seeking behaviors such as doctor or pharmacy shopping.
Contextual Factors’ Impact on the Reception of Substance Use Disorder Treatment Language: An Interpretative Phenomenological Analysis
Published in Alcoholism Treatment Quarterly, 2022
Rebecca Lucero Jones, Stephen T. Fife, Jason T. Cravens
Despite the considerable costs to individuals, families, and society, many individuals in need of treatment fail to receive services at a specialized facility. Estimates suggest that at best only 10–11% of those in need of treatment receive services at a specialty treatment center; and over 20 million Americans, or 89% of persons with substance-related disorders, fail to receive services at all (Center for Behavioral Health Statistics and Quality [CBHSQ], 2016; SAMHSA, 2008). One may wonder why so many individuals do not obtain professional help, especially when studies have shown that effective interventions and treatments significantly reduce the burdensome costs to individuals and society (Rehm, Taylor, & Room, 2006). Among the multifaceted reasons that persons with a substance-related disorder do not seek treatment, stigma ranks as a critical determinant. SAMHSA (2008) conducted a national survey on health and drug use in America in both 2007 and 2013 (CBHSQ, 2016). Data collected from 2004–2007 revealed that of those who needed treatment for a substance-related disorder, a significant portion of participants indicated that stigma played a factor for not seeking treatment. For those who felt they needed professional assistance for alcohol or illicit drug use but had not sought out services, 11.1% reported feeling concern that neighbors or their community would view them more negatively for receiving treatment. Additionally, the study revealed that 11.6% of participants worried that treatment would have a negative impact on their job.